Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

OncoTherapy Science Inc

4564.T ✓ COMPLIANT ☆ Track — members

Tokyo Exchange · Healthcare · Biotechnology & Medical Research ·

Japan Micro Cap Analyst: N/A

Last Close

$0.13

▲ +0.00%

Market Cap $53.89M · Vol 187.15M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$53.89M

Micro Cap

Div Yield

0.00%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

62.50

Momentum

Beta

0.33

vs Market

52W High

$0.21

40.63% below

52W Low

$0.11

19.16% above

Volume

187.15M

Avg 191.51M

P/B

3.76

Price-to-book

ROE

N/A

Return on equity

Free Float

88.54%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, OncoTherapy Science Inc (4564.T) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does 4564.T pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-8.70%

+5.00%

YTD

+5.00%

-25.00%

-37.68%

-75.29%

Financials & Valuation

TTM · Annual

Total Revenue	$5.09M
Net Income	$-5,737,748.00
Revenue Growth (YoY)	-15.25%
Gross Margin	1.73%
Operating Margin	-100.23%
Net Profit Margin	-112.63%
ROE	N/A
ROA · ROIC	-51.70% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	8.53
P/B	3.76
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	408.24M

Technical Indicators

50-Day SMA	$0.12
200-Day SMA	$0.13
RSI (14)	62.50
Beta	0.33
52-Week High	$0.21
52-Week Low	$0.11

Volume Today	187.15M
Avg Daily Volume (30D)	191.51M
Relative Volume	0.98x
Volatility (10D)	66.40
Volatility (30D)	62.08
Free Float	88.54%

Analyst Consensus

N/A

Current Price $0.13

Mean Target N/A

52W Low$0.11 52W High$0.21

Current

Target

$0.11 $0.21

Current Analyst target

· 0 analysts

Identifiers

ExchangeTokyo Exchange

FIGIBBG001SDH6B4

ISINJP3202150003

CountryJapan

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd +3.29% ARGX.BR argenx SE +1.74% ARGX argenx SE +0.83% 2269.HK WuXi Biologics (Cayman) Inc +7.41% INSM Insmed Inc -0.07%

Company Profile

OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.